UBE2L3 and hepatocellular carcinoma: In liver cancer and oral squamous cell carcinoma, UBE2L3 was reported to be an important pro-tumorigenic factor in carcinogenesis [44, 45] and may be a potential treatment target for hepatocellular carcinoma [46].